Valuation West Pharmaceutical Services, Inc. Boerse Muenchen

Stocks

Market Closed - Boerse Muenchen 16:43:38 2026-08-28 EDT			5-day change	1st Jan Change
291.55 ^EUR	-2.03%		-3.60%	+25.78%

08-26	Boston Scientific hit by cyberattack, global operations affected	RE
08-03	Is everything under control?

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	34,744	17,424	26,053	23,723	19,795	23,750	-	-
Change	-	-49.85%	49.53%	-8.95%	-16.56%	19.98%	-	-
Enterprise Value (EV) ¹	34,744	16,738	25,406	23,441	19,206	23,246	22,711	22,291
Change	-	-51.82%	51.78%	-7.74%	-18.07%	21.04%	-2.31%	-1.85%
P/E	54.1x	30.4x	44.7x	49x	40.5x	39.4x	34.2x	30.6x
PBR	14.9x	6.5x	8.98x	8.83x	5.95x	7.58x	6.62x	5.85x
PEG	-	-2.8x	23.04x	-3.2x	27.09x	1.5x	2.3x	2.6x
Capitalization / Revenue	12.3x	6.04x	8.83x	8.2x	6.44x	7.04x	6.62x	6.16x
EV / Revenue	12.3x	5.8x	8.61x	8.1x	6.25x	6.89x	6.33x	5.78x
EV / EBITDA	39.3x	19x	30.7x	32.2x	24.2x	24.7x	21.8x	19.2x
EV / EBIT	45.6x	22x	36.8x	40.9x	30.9x	30.7x	26.8x	23.4x
EV / FCF	105x	38.1x	61.3x	84.8x	41x	54x	40x	30.7x
FCF Yield	0.95%	2.63%	1.63%	1.18%	2.44%	1.85%	2.5%	3.25%
Dividend per Share ²	0.69	0.74	0.78	0.82	0.85	0.9025	0.9729	1.121
Rate of return	0.15%	0.31%	0.22%	0.25%	0.31%	0.27%	0.29%	0.33%
EPS ²	8.67	7.73	7.88	6.69	6.79	8.575	9.865	11.04
Distribution rate	7.96%	9.57%	9.9%	12.3%	12.5%	10.5%	9.86%	10.2%
Net sales ¹	2,832	2,887	2,950	2,893	3,074	3,375	3,587	3,854
EBITDA ¹	884.7	882.6	827.9	728.2	793.8	940.4	1,041	1,159
EBIT ¹	762.4	762	690.6	572.8	622.4	757.5	848.4	952.3
Net income ¹	661.8	585.9	593.4	492.7	493.7	614.5	701.2	778
Net Debt ¹	-	-685.4	-647.1	-282	-588.5	-503.3	-1,039	-1,458
Reference price ²	469.01	235.35	352.12	327.56	275.14	337.47	337.47	337.47
Nbr of stocks (in thousands)	74,080	74,033	73,990	72,422	71,943	70,376	-	-
Announcement Date	2/17/22	2/16/23	2/15/24	2/13/25	2/12/26	-	-	-